Bixiye
P9-25 Specialty Utilization Management (UM) Program: Advanced Imaging Clinical Guideline Updates
Taariikhda uu dhaqangalayo Barnaamijka: Mar 03, 2025
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 471 - 480 ee natiijooyinka 3167
Annaga Nagu Saabsan
2024 Code of Conduct
Bixiye
Inhaled Antibiotics Duplicate Therapy - Medicaid - Effective Date 03/01/2025
Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Mar 01, 2025
Bixiye
Buprenorphine_Buprenorphine_Naloxone - Medicaid - 03/01/2025
Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Mar 01, 2025
Bixiye
Ketorolac - Medicaid - Effective Date 03/01/2025
Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Mar 01, 2025
Bixiye
Ketorolac - Commercial - Effective Date 03/01/2025
Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Mar 01, 2025
Bixiye
Buprenorphine_Buprenorphine_Naloxone - Commercial - Effective Date 03/01/2025
Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Mar 01, 2025
Bixiye
Kerendia® - Commercial - Effective Date 03/01/2025
Step Therapy, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Mar 01, 2025
Bixiye
Kerendia® - Medicaid - Effective Date 03/01/2025
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Mar 01, 2025
Bixiye
VMAT2 Inhibitors (Vesicular Monoamine Transporter 2) - Commercial - Effective Date 03/01/2025
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Mar 01, 2025